A commentary on “Survival benefit of liver resection following complete response to transarterial chemoembolization for intermediate-stage hepatocellular carcinoma: a retrospective, multicenter, cohort study”

aInstitute of Molecular Medicine (IMM), Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University, Shanghai 200240, China bDepartment of Oncology,Fudan University Shanghai Cancer Center,Shanghai Medical College, Fudan University, Shanghai 200032, China cSchool of Life Sciences, Fudan University, Shanghai 200438, China dDepartment of Hepatobiliary and Pancreatic Surgery, Harbin Medical University Cancer Hospital, 150000, Harbin, Heilongjiang, China Chunhua Rui, Longhuan Piao Co-authors: Chunhua Rui and Longhuan Piao equally Peng Wang contributed to the article. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article Published online ■ ■ *Corresponding Author. Address: Department of Hepatobiliary and Pancreatic Surgery, Harbin Medical University Cancer Hospital, 150000, Harbin, Heilongjiang, China. E-mail address: [email protected] (P. Wang). This is an open access article distributed under the Creative Commons Attribution-ShareAlike License 4.0, which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms. http://creativecommons.org/licenses/by-sa/4.0/